Literature DB >> 11524896

[Evaluated treatment approaches in child and adolescent psychiatry I].

L Baving1, M H Schmidt.   

Abstract

OBJECTIVES: The principle of evidence-based medicine is to integrate data concerning the efficacy of interventions into clinical practice. This article assesses the level of evaluation of psychosocial, psychopharmacological and combined interventions for mental disorders in childhood and adolescence (autistic disorders, hyperkinetic disorders, conduct disorders, tic disorders, enuresis, and encopresis).
METHODS: Three different levels of evaluation were defined for both psychosocial and psychopharmacological interventions: A (> or = 2 randomized controlled studies), B (1 randomized controlled study), and C (open studies and case studies). The level of evaluation was judged on the basis of original papers found in a comprehensive literature search.
RESULTS: For most disorders presented in this article there are several A-level treatments. The efficacy of both psychosocial and psychopharmacological interventions that target specific problem behaviors or symptoms, respectively, has been repeatedly demonstrated with regard to autistic disorders. Many studies have evaluated treatment approaches for hyperkinetic disorders and conduct disorders. With regard to the treatment of tic disorders in children and adolescents, far more studies evaluated the efficacy of pharmacotherapy than of psychotherapy.
CONCLUSIONS: Further research should compare the efficacy of different treatment approaches, examine specific and differential treatment effects and investigate combined treatment approaches.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11524896     DOI: 10.1024//1422-4917.29.3.189

Source DB:  PubMed          Journal:  Z Kinder Jugendpsychiatr Psychother        ISSN: 1422-4917


  1 in total

1.  The effectiveness of child and adolescent psychiatric treatments in a naturalistic outpatient setting.

Authors:  Mareile Bachmann; Christian J Bachmann; Katja John; Monika Heinzel-Gutenbrunner; Helmut Remschmidt; Fritz Mattejat
Journal:  World Psychiatry       Date:  2010-06       Impact factor: 49.548

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.